Clinical Trials in Texas

Showing 7801-7820 of 15,101 trials

Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age

NCT01310413

This study will assess safety and immunogenicity of GSK Biologicals' H5N1 flu candidate vaccine GSK1557484A in children 6 months to \< 18 years of age.

InfluenzaInfluenza Vaccines

GlaxoSmithKline842 participantsStarted Mar 2011

Paramount, California, United States • Sacramento, California, United States • Newton, Kansas, United States +14 more locations

COMPLETEDPhase 3119 miles

An Efficacy, Safety, and Pharmacokinetics Study of Subcutaneously Administered Ustekinumab in the Treatment of Moderate to Severe Chronic Plaque Psoriasis in Pediatric Participants Greater Than or Equal to 6 to Less Than 12 Years of Age

NCT02698475

The purpose of this study is to evaluate the efficacy and safety of ustekinumab in pediatric participants aged greater than or equal to (\>=) 6 through less than (\<) 12 years with moderate to severe chronic plaque psoriasis

Psoriasis

Janssen Research & Development, LLC44 participantsStarted May 2016

San Diego, California, United States • Chicago, Illinois, United States • Indianapolis, Indiana, United States +28 more locations

Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age

An Efficacy, Safety, and Pharmacokinetics Study of Subcutaneously Administered Ustekinumab in the Treatment of Moderate to Severe Chronic Plaque Psoriasis in Pediatric Participants Greater Than or Equal to 6 to Less Than 12 Years of Age

Find Trials by Condition in Texas

Rituxan/BEAM vs Bexxar/BEAM in Autologous Hematopoietic Stem Cell Transplant for Non-Hodgkin's Lymphoma (BMTCTN0401)

Stem Cell Transplantation in Individuals With Multiple Myeloma (BMT CTN 0102)

A Study of HIV-Disease Development in Aging

A Study to Evaluate Steroid-free Treatment for Standard-Risk aGVHD (BMT CTN 1501)

Safety and Effectiveness of the Oral HIV Entry Inhibitor Vicriviroc in HIV Infected Patients

34mm Cuff Study for Endovascular Repair of Abdominal Aortic Aneurysms

Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis

A Study of the Safety and Effectiveness of Treating Advanced AIDS Patients Between Ages 4 and 22 With 7 Drugs, Some at Higher Than Usual Doses

A Study of Megestrol Acetate Alone or in Combination With Testosterone Enanthate Drug in the Treatment of HIV-Associated Weight Loss

A Study of Pentamidine Plus Dapsone in the Prevention of Pneumocystis Carinii Pneumonia (PCP) in HIV-Infected Patients Who Cannot Take Trimethoprim or Sulfonamides

Safety and Effectiveness of Lopinavir/Ritonavir in HIV Infected Infants

The Safety and Effectiveness of Clarithromycin and Rifabutin Used Alone or in Combination to Prevent Mycobacterium Avium Complex (MAC) or Disseminated MAC Disease in HIV-Infected Patients

The Effectiveness of Three Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Never Used Anti-HIV Drugs

A Study of DAPD Alone Versus DAPD Plus MMF for Treatment of HIV Infection

Effect of an Intrauterine Contraceptive Device (IUD) in HIV Infected Women

Drug Interactions of Amprenavir and Efavirenz, in Combination With a Second Protease Inhibitor, in HIV-Negative Volunteers

Using Drug Levels and Drug Resistance Testing to Select Effective Anti-HIV Drug Combinations in Patients With Drug-resistant HIV

Adding New Drugs for HIV Infected Patients Failing Current Therapy